Analyzing T Cell Responses (eBook)
XII, 314 Seiten
Springer Netherland (Verlag)
978-1-4020-3623-1 (ISBN)
Active specific immunotherapy is a promising but investigational modality in the management of cancer patients. Currently, several different cancer vaccine formulations such as peptides, proteins, antigen-pulsed dendritic cells, whole tumor cells, etc. in combination with various adjuvants and carriers are being evaluated in clinical trials (1-3). To determine the optimal cancer vaccine strategy, a surrogate immunological end-point that correlates with clinical outcome needs to be defined, since it would facilitate the rapid comparison of these various formulations. Traditional immunological assays such as ELISA, proliferation and cytotoxicity assays can detect immune responses in vaccinated patients but are not quantitative. In contrast, novel assays such as enzyme-linked immunospot (ELISPOT) assay, intracellular cytokine assay and tetramer assay can quantitate the frequency of antigen-specific T cells. Of these, the ELISPOT assay has the 5 lowest detection limit with 1/10 peripheral blood mononuclear cells (PBMC) and has been determined to be one of the most useful assays to evaluate immune response to cancer vaccines (4). However, the IFN-? ELISPOT assay is not an exclusive measure of cytotoxic T-lymphocyte (CTL) activity as non-cytotoxic cells can also secrete IFN-?. Additionally, CTL with lytic activity do not always secrete IFN-? (5). A more relevant approach to assess functional activity of cytotoxic lymphocytes would be to measure the secretion of molecules that are associated with lytic activity. One of the major mechanisms of cell-mediated cytotoxicity involves exocytosis of cytoplasmic granules from the effector toward the target cell.
Chapter 1: Monitoring Antigen-Specific T Cell Responses; Dirk Nagorsen, Francesco M. Marincola
Chapter 2: Tumor Associated Antigens; Paul F. Robbins
Chapter 3: Immune Escape, Tumor induced immune suppression and immune escape: Mechanisms and Possible Solutions; Theresa L. Whiteside, Michael Campoli, Soldano Ferrone
Chapter 4: Virus Specific T-Cell Responses; Victor Appay
Chapter 5: Cytotoxicity Assays Killer Lymphocytes in Cancer; Gideon Berke & William R. Clark
Chapter 6: Monitoring T Cell Proliferation; Philip D. Hodgkin, Edwin D. Hawkins, Jhaguaral Hasbold, Amanda V. Gett, Elissa K. Deenick, Hilary F. Todd & Mirja Hommel
Chapter 7: Elispot Assay, Assessment of Cellular Immune Responses to Anti-Cancer Vaccines; Theresa L. Whiteside
Chapter 8: Modified Elispot, Modifications of the Elispot Assay for T Cell Monitoring in Cancer Vaccine Trials; Anatoli Malyguine
Chapter 9: Intracellular Cytokine Staining, Cytokine flow cytometry for characterization of tumor-specific T cell responses; Carmen Scheibenbogen, Anne Letsch, Anne Marie Asemissen, Alexander Schmittel, Eckhard Thiel & Ulrich Keilholz
Chapter 10: Cytometric Cytokine Secretion Assay, Detection and Isolation of Antigen-Specific T Cells; Mario Assenmacher
Chapter 11: Peptide/MHC Tetramer Analysis; Peter P. Lee & Francesco M. Marincola
Chapter 12: In Situ MHC Tetramer Staining, In Situ Tetramers; Pamela J. Skinner
Chapter 13: MHC-IG Dimeric Molecules, Dimers - MHC-Ig dimeric molecules for the analysis of antigen-specific T cell responses; Tim F. Greten & Firouzeh Korangy
Chapter 14: TCR Analyses, T-cell receptor CDR3 analysis: Molecular fingerprinting of the T-cell receptor repertoire; Markus J. Maeurer
Chapter 15: Peptide/HLA-GFP Complexes, Detection of Antigen-Specific T Cells by Acquisition of Peptide/Hla-Gfp Complexes; Utano Tomaru, Yoshihisa Yamano & Steven Jacobson
Chapter 16: QRT-PCR, Quantitative RT-PCR for the Analysis of T cell Responses in Immunized Cancer Patients; Udai S. Kammula
Chapter 17: Microarrays, Gene expression profiling approaches for the monitoring of anti-cancer immune responses; Ena Wang
Concluding Remarks; Dirk Nagorsen & Francesco M. Marincola
| Erscheint lt. Verlag | 16.1.2006 |
|---|---|
| Zusatzinfo | XII, 314 p. |
| Verlagsort | Dordrecht |
| Sprache | englisch |
| Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Innere Medizin |
| Medizin / Pharmazie ► Medizinische Fachgebiete ► Onkologie | |
| Studium ► Querschnittsbereiche ► Infektiologie / Immunologie | |
| Naturwissenschaften ► Biologie | |
| Technik | |
| Schlagworte | Antigen • Cancer • Cell • Cytokine • Cytotoxicity • Gene • gene expression • immunology • immunotherapy • Lymphocytes • Proliferation • T Cell • Tumor • Vaccine • Virus |
| ISBN-10 | 1-4020-3623-X / 140203623X |
| ISBN-13 | 978-1-4020-3623-1 / 9781402036231 |
| Haben Sie eine Frage zum Produkt? |
PDF (Wasserzeichen)Größe: 8,8 MB
DRM: Digitales Wasserzeichen
Dieses eBook enthält ein digitales Wasserzeichen und ist damit für Sie personalisiert. Bei einer missbräuchlichen Weitergabe des eBooks an Dritte ist eine Rückverfolgung an die Quelle möglich.
Dateiformat: PDF (Portable Document Format)
Mit einem festen Seitenlayout eignet sich die PDF besonders für Fachbücher mit Spalten, Tabellen und Abbildungen. Eine PDF kann auf fast allen Geräten angezeigt werden, ist aber für kleine Displays (Smartphone, eReader) nur eingeschränkt geeignet.
Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen dafür einen PDF-Viewer - z.B. den Adobe Reader oder Adobe Digital Editions.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen dafür einen PDF-Viewer - z.B. die kostenlose Adobe Digital Editions-App.
Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.
aus dem Bereich
